ScholarIQanswers from OpenAlex & ORCID
Andrew E. Moran
ResearcherPublications, citations & collaboration network
Andrew E. Moran is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Andrew E. Moran have?
ScholarIQindexed works
Andrew E. Moran has 391 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andrew E. Moran have?
ScholarIQcitation count
Andrew E. Moran has 32,750 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Andrew E. Moran?
ScholarIQh-index
Andrew E. Moran has an h-index of 59 in OpenAlex.
What is the i10-index of Andrew E. Moran?
ScholarIQi10-index
Andrew E. Moran has an i10-index of 160 in OpenAlex.
What is the ORCID of Andrew E. Moran?
ScholarIQorcid
The ORCID for Andrew E. Moran is on the source record.
What is the OpenAlex record for Andrew E. Moran?
ScholarIQopenalex
The OpenAlex for Andrew E. Moran is on the source record.
What are the most-cited papers on Andrew E. Moran?
ScholarIQmost cited works
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Salim S. Virani, Álvaro Alonso, Emelia J. Benjamin, Márcio Sommer Bittencourt, Clifton W. Callaway, April P. Carson, Alanna M. Chamberlain, Alex R. Chang, Susan Cheng, Francesca N. Delling, Luc Djoussé, Mitchell S.V. Elkind, Jane F. Ferguson, Myriam Fornage, Sadiya S. Khan, Brett Kissela, Kristen L. Knutson, Tak Kwan, Daniel T. Lackland, Tené T. Lewis, Judith H. Lichtman, Chris T. Longenecker, Matthew Shane Loop, Pamela L. Lutsey, Seth S. Martin, Kunihiro Matsushita, Andrew E. Moran, Michael E. Mussolino, Amanda M. Perak, Wayne D. Rosamond, Gregory A. Roth, Uchechukwu K.A. Sampson, Gary Satou, Emily B. Schroeder, Svati H. Shah, Christina M. Shay, Nicole L. Spartano, Andrew Stokes, David Tirschwell, Lisa B. VanWagner, Connie W. Tsao
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Emelia J. Benjamin, Paul Muntner, Álvaro Alonso, Márcio Sommer Bittencourt, Clifton W. Callaway, April P. Carson, Alanna M. Chamberlain, Alex R. Chang, Susan Cheng, Sandeep R. Das, Francesca N. Delling, Luc Djoussé, Mitchell S.V. Elkind, Jane F. Ferguson, Myriam Fornage, Lori Chaffin Jordan, Sadiya S. Khan, Brett Kissela, Kristen L. Knutson, Tak Kwan, Daniel T. Lackland, Tené T. Lewis, Judith H. Lichtman, Chris T. Longenecker, Matthew Shane Loop, Pamela L. Lutsey, Seth S. Martin, Kunihiro Matsushita, Andrew E. Moran, Michael E. Mussolino, Martín O’Flaherty, Ambarish Pandey, Amanda M. Perak, Wayne D. Rosamond, Gregory A. Roth, Uchechukwu K.A. Sampson, Gary Satou, Emily B. Schroeder, Svati H. Shah, Nicole L. Spartano, Andrew Stokes, David Tirschwell, Connie W. Tsao, Mintu P. Turakhia, Lisa B. VanWagner, John T. Wilkins, Sally S. Wong, Salim S. Virani
Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease
Kirsten Bibbins‐Domingo, Glenn M. Chertow, Pamela G. Coxson, Andrew E. Moran, James Lightwood, Mark J. Pletcher, Lee Goldman
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Michael G. Shlipak, Sri Lekha Tummalapalli, L. Ebony Boulware, Morgan E. Grams, Joachim H. Ix, Vivekanand Jha, André Pascal Kengne, Magdalena Madero, Borislava Mihaylova, Navdeep Tangri, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer, Sophia Zoungas, Georgi Abraham, Zanfina Ademi, Radica Z. Alicic, Ian H. de Boer, Raj Deo, Xiaoqiang Ding, Natalie Ebert, Kevin Fowler, Linda F. Fried, Ron T. Gansevoort, Guillermo García-García, Brenda R. Hemmelgarn, Jessica L. Harding, Joanna Q. Hudson, Kunitoshi Iseki, Vasantha Jotwani, Leah Karliner, Andrew S. Levey, Adrian Liew, Peter Lin, Andrea O. Y. Luk, V. Rodríguez Martínez, Andrew E. Moran, Mai Ánh Nguyễn, Gregorio T. Obrador, Dónal O’Donoghue, Meda E. Pavkov, Jessie Pavlinac, Neil R. Powe, Jesse C. Seegmiller, Jenny I. Shen, Rukshana Shroff, Laura Solá, Maarten W. Taal, James Tattersall, Joseph A. Vassalotti, Matthew R. Weir, Ella Zomer
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
Dhruv S. Kazi, Andrew E. Moran, Pamela G. Coxson, Joanne Penko, Daniel A. Ollendorf, Steven D. Pearson, Jeffrey A. Tice, David Guzman, Kirsten Bibbins‐Domingo